FDA Approves Oral Tx for Alopecia – Litfulo
The FDA recently approved a new therapy, Litfulo (ritlecitinib) from Pfizer, Inc., a once-daily oral treatment, for individuals 12 years of age and older with
July 27, 2023
The FDA recently approved a new therapy, Litfulo (ritlecitinib) from Pfizer, Inc., a once-daily oral treatment, for individuals 12 years of age and older with
Every day we scan hundreds of articles and press releases to find items, events, trends, developments and other flotsam and jetsam related to specialty pharmacy,
Are you familiar with the Preserving Patient Access to Home Infusion Act (PPAHIA)? You probably should be. It has been kicking around the halls of
FDA has now approved four gene therapies within the past ninety days. That’s got to be a record! The FDA recently approved a new infused
Not all specialty pharmacies operate a compounding line of business….. but there are a number of SPs that do. If your pharmacy is into compounding, then you
Another sonic boom could be heard (well….. at least by dogs) recently when the FDA approved yet another gene therapy! This time the news was truly
The FDA recently approved a new infused therapy, Columvi (glofitamab-gxbm) from Genentech, for the treatment of adult patients with relapsed or refractory (R/R) diffuse large
A boatload of biosimilars are now sitting in the approval circle since the first one was approved in early 2015. Copies of just four market
Lots of angst between the FEDA and Pharma over drug pricing controls and price negotiations. There will be lobbying a’plenty by Pharma to mitigate what is already
The FDA recently approved a new extended release oral-suspension therapy, Lumryz (sodium oxybate) from Avadel Pharmaceuticals, for the treatment of cataplexy or excessive daytime sleepiness
